Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate I Bugan, S Kucuk, Z Karagoz, SP Fraser, H Kaya, A Dodson, CS Foster, ... Prostate cancer and prostatic diseases 22 (4), 569-579, 2019 | 38 | 2019 |
Gabapentin, an Analgesic Used Against Cancer‐Associated Neuropathic Pain: Effects on Prostate Cancer Progression in an In Vivo Rat Model I Bugan, Z Karagoz, S Altun, MBA Djamgoz Basic & clinical pharmacology & toxicology 118 (3), 200-207, 2016 | 27 | 2016 |
Brain boron level, DNA content, and myeloperoxidase activity of metformin-treated rats in diabetes and prostate cancer model AB Ozel, E Dagsuyu, PK Aydın, I Bugan, OK Bulan, R Yanardag, A Yarat Biological Trace Element Research 200 (3), 1164-1170, 2022 | 12 | 2022 |
The protective effect of metformin against testicular damage in diabetes and prostate cancer model P Koroglu Aydın, O Karabulut‐Bulan, I Bugan, IB Turkyilmaz, S Altun, ... Cell Biochemistry and Function 40 (1), 60-70, 2022 | 12 | 2022 |
Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model P Koroglu-Aydın, BB Bayrak, I Bugan, O Karabulut-Bulan, R Yanardag Toxicology Mechanisms and Methods 31 (7), 489-500, 2021 | 12 | 2021 |
Anti-metastatic effect of riluzole on Mat-LyLu rat prostate cancer cell line S Uzun, S Altun, İ Bugan Annals of Oncology 28, x3, 2017 | 2 | 2017 |
In vivo sıçan prostat kanser hücreleri ve voltaj kapılı sodyum kanal ekspresyonu: metastatik potansiyelin değerlendirilmesinde yeni stratejiler ve moleküler yaklaşımlar S ALTUN, H GÜMÜŞHAN, H KAYA, M DJAMGOZ, İ BUGAN, Z KARAGÖZ, ... | 2 | 2014 |
Inhibitory Effects of Dunning Rat Prostate Tumor Fluid on Proliferation of the Metastatic MAT-LyLu Cell Line I Bugan, S Altun Asian Pacific Journal of Cancer Prevention 16 (2), 831-836, 2015 | 1 | 2015 |
Dunning sıçan prostat tümör sıvısının MAT-LyLu hücreleri üzerine etkisi İ Bugan Fen Bilimleri Enstitüsü, 2009 | 1 | 2009 |
New study on metformin action against testicular injury: prostate cancer, diabetes and diabetes-cancer connection P Koroglu, O Karabulut-Bulan, IB Turkyilmaz, I Bugan, R Yanardag BOOK OF ABSTRACTS, 380, 0 | 1 | |
Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model (vol 31, pg 489, 2022) P Koroglu-Aydin, BB Bayrak, I Bugan, O Karabulut-Bulan, R Yanardag TOXICOLOGY MECHANISMS AND METHODS, 2022 | | 2022 |
The protective effect of metformin against testicular damage in diabetes and prostate cancer model PK Aydın, O Karabulut-Bulan, I Bugan, IB Turkyilmaz, S Altun, ... Cell Biochem Funct 40 (1), 60-70, 2022 | | 2022 |
Riluzole and ranolazine application of prostate cancer: Cancer related testicular and liver tissue damage PK Aydin, I Bugan Experimental Biomedical Research 5 (1), 10-22, 2022 | | 2022 |
Metformin ameliorates testicular damage in diabetes and prostate cancer model P Koroglu, OK Bulan, IB Turkyılmaz, I Bugan, S Altun, R Yanardag European Microscopy Congress 2016: Proceedings, 165-165, 2016 | | 2016 |
Meformin diyabet ve Prostat kanser modelinde testiküler hasarı düzeltir P Köroğlu, N Bulan, İ Türkyılmaz, İ Bugan, S Altun, R Yanardağ | | |
SIÇAN PROSTAT KANSERİ MODELİNDE VOLTAJ KAPILI NA KANAL AKTİVİTESİNİN GABAPENTİN İLE DEĞERLENDİRİLMESİ: İN VİTRO VE İN VİVO ANALİZLER İ BUGAN, S ALTUN | | |
Meformin diyabet ve Prostat kanser modelinde testiküler hasarı düzeltir İB Türkyılmaz, R Yanardağ, NÖ Bulan, İ Bugan, S Altun, P Köroğlu | | |
Metforminin Dunning Prostat Kanser Modelinde Karaciğer Hasarı Üzerine Etkileri İ Türkyılmaz, P Köroğlu, İ Bugan, N Bulan, R Yanardağ | | |